Synergy between SH-003 and docetaxel against refractory lung cancer
Cancer Lung cancer is globally the second most frequent cancer and the cause of approximately 2 of every 10 cancer-related deaths. Immune checkpoint inhibitor therapy can be effective for some patients, but many patients prove resistant to it. BioWorld …